Spirovant Sciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.spirovant.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
Phase 1
Recruiting
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Spirovant Sciences, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT06526923
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
🇺🇸Boston Children's Hospital, Brigham & Women's Hospital, Boston, Massachusetts, United States
🇺🇸Columbia University, New York, New York, United States
News
No news found